Berkeley Lights, Inc. (BLI) Stock Rising in Aftermarket, Here’s the Reason


Berkeley Lights, Inc. (BLI), a digital company related to the field of cell biology, has gained an increase of 1.74 percentage points, and hence, was trading at $6.42 when last checked. During Wednesday’s regular trading session, the stock rose by 6.41% to close the day at $6.31. The stock is on the rise owing to a new appointment in the executive setup of the company.

25-cent Stock Takes $11T Commodities Sector Digital

One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.

All the details are in the FREE online report you can get here.


Appointment of CEO

On Wednesday, BLI announced the appointment of Dr. Siddhartha Kadia in the role of CEO of the company. Before Dr. Kadia, Eric D. Hobbs, Ph.D. was serving as the Chief Executive Officer of the company. Dr. Kadia has experience of more than 2 decades in leadership positions. Alongside, his expertise also encompasses life sciences technologies and services. Before joining Berkeley, he was serving as president and CEO of EAG Laboratories.

Participation in Festival of Biologics Meeting

On the 4th of March, BLI reported that it would be participating in the Festival of Biologics meeting. The meeting was to be held from 9th of March to 11th of March, 2022. The festival is aimed at bringing together numerous institutes from the biotech industry, pharma industry, research institutes, and Academia as well as other ones in the area of immunotherapy, antibodies, etc. At the festival, Berkeley would show the Berkeley Lights Platform and single B-cell antibody discovery workflow.

BLI Released Upgrade to Software Suite

On the 3rd of March, BLI released an upgrade to its Software Suite. The upgrade included the enhancement in Cell Analysis Suite, Assay Analyzer and Image Analyzer meant for the Berkeley Lights Beacon and Lightning Systems. The company said that the installation of new features would serve the purpose of delivering easier insights, faster throughput operations for cell line development and cell therapy workflows.

What’s Next for BLI?

According to analysts, BLI stock holds a negative evaluation, as the technical indicators are pointing towards a bleak future for the stock in the next few weeks. Investors should take careful decisions keeping in mind this forecast.


Please enter your comment!
Please enter your name here